Acute Myeloid Leukemia (AML) Therapeutics Market
Global Acute Myeloid Leukemia (AML) Therapeutics Strategic Research Report 2023: Market to Reach $1.6 Billion by 2030 with Cytarabine Accounting for $571.6 Million
December 05, 2023 10:48 ET | Research and Markets
Dublin, Dec. 05, 2023 (GLOBE NEWSWIRE) -- The "Acute Myeloid Leukemia (AML) Therapeutics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Acute...
22157.jpg
Global Acute Myeloid Leukemia (AML) Therapeutics Market Report 2022 to 2030: Players Include Abbott Laboratories, Boehringer Ingelheim, Cephalon and Eisai
February 01, 2023 12:13 ET | Research and Markets
Dublin, Feb. 01, 2023 (GLOBE NEWSWIRE) -- The "Acute Myeloid Leukemia (AML) Therapeutics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive...
22157.jpg
Global Acute Myeloid Leukemia (AML) Therapeutics Market Report 2021: Market to Reach $976.2 Billion by 2026 - Emerging Drug Therapies/Targeted Therapies to Drive Future Growth
December 06, 2021 03:38 ET | Research and Markets
Dublin, Dec. 06, 2021 (GLOBE NEWSWIRE) -- The "Acute Myeloid Leukemia (AML) Therapeutics - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering....